Jacques P. Tremblay

12.7k total citations · 1 hit paper
289 papers, 9.6k citations indexed

About

Jacques P. Tremblay is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Jacques P. Tremblay has authored 289 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 252 papers in Molecular Biology, 76 papers in Genetics and 62 papers in Surgery. Recurrent topics in Jacques P. Tremblay's work include Muscle Physiology and Disorders (169 papers), Mesenchymal stem cell research (53 papers) and Virus-based gene therapy research (49 papers). Jacques P. Tremblay is often cited by papers focused on Muscle Physiology and Disorders (169 papers), Mesenchymal stem cell research (53 papers) and Virus-based gene therapy research (49 papers). Jacques P. Tremblay collaborates with scholars based in Canada, United States and France. Jacques P. Tremblay's co-authors include Daniel Skuk, Raynald Roy, M Goulet, Jean‐Thomas Vilquin, Brigitte Roy, Pierre Chapdelaine, Nicolas Caron, Johnny Huard, Ikuo Kinoshita and Isabelle Asselin and has published in prestigious journals such as Nature, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Jacques P. Tremblay

282 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current Clinical Applications of In Vivo Gene Therapy with AAVs

2020 483 citations Jacques P. Tremblay et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques P. Tremblay Canada	50	8.1k	3.0k	2.6k	1.9k	1.1k	289	9.6k
Grace K. Pavlath United States	51	7.2k 0.9×	1.6k 0.5×	1.3k 0.5×	943 0.5×	806 0.8×	103	9.0k
Michael Kyba United States	55	9.8k 1.2×	2.0k 0.7×	1.4k 0.5×	1.2k 0.7×	504 0.5×	173	12.0k
Martín F. Pera Australia	55	10.4k 1.3×	2.9k 1.0×	1.3k 0.5×	1.1k 0.6×	1.3k 1.3×	154	12.5k
Terence A. Partridge United Kingdom	60	13.0k 1.6×	4.6k 1.5×	3.8k 1.5×	1.9k 1.0×	938 0.9×	130	14.7k
Michal Amit Israel	30	8.2k 1.0×	3.7k 1.3×	1.2k 0.5×	762 0.4×	881 0.8×	45	9.8k
Junying Yu United States	27	14.2k 1.7×	3.3k 1.1×	1.6k 0.6×	1.4k 0.8×	1.8k 1.7×	29	16.3k
Andrew G. Elefanty Australia	51	7.6k 0.9×	2.5k 0.9×	976 0.4×	1.2k 0.6×	1.1k 1.0×	164	11.0k
Stephen D. Hauschka United States	61	9.7k 1.2×	1.5k 0.5×	830 0.3×	2.4k 1.3×	939 0.9×	121	12.0k
Vincent Mouly France	56	7.1k 0.9×	1.6k 0.5×	1.4k 0.5×	790 0.4×	932 0.9×	206	9.0k
Anna M. Wobus Germany	47	5.9k 0.7×	2.3k 0.8×	746 0.3×	973 0.5×	896 0.9×	103	7.6k

Countries citing papers authored by Jacques P. Tremblay

Since Specialization

Citations

This map shows the geographic impact of Jacques P. Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques P. Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques P. Tremblay more than expected).

Fields of papers citing papers by Jacques P. Tremblay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques P. Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques P. Tremblay. The network helps show where Jacques P. Tremblay may publish in the future.

Co-authorship network of co-authors of Jacques P. Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques P. Tremblay. A scholar is included among the top collaborators of Jacques P. Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques P. Tremblay. Jacques P. Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burga, Rachel A., Bülent Arman Aksoy, Zheng Ao, et al.. (2025). IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15. Molecular Therapy. 33(8). 3605–3623. 4 indexed citations

Leroux, Isabelle, Thibaut Larcher, Antoine Hamel, et al.. (2024). Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept study. Journal of Neuropathology & Experimental Neurology. 83(8). 684–694. 1 indexed citations

Gérard, Catherine, et al.. (2023). Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral Phenotype. Genes. 14(8). 1654–1654. 4 indexed citations

Carbonneau, Julie, Charles Joly Beauparlant, Thierry Vincent, et al.. (2023). Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13. The CRISPR Journal. 6(4). 369–385. 2 indexed citations

Tremblay, Guillaume, et al.. (2022). Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease. The CRISPR Journal. 5(1). 109–122. 24 indexed citations

Song, Bo, et al.. (2022). Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases. SHILAP Revista de lepidopterología. 4. 892769–892769. 8 indexed citations

Gérard, Catherine, Xiao Xiao, Mohammed Filali, et al.. (2014). An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models. Molecular Therapy — Methods & Clinical Development. 1. 14044–14044. 40 indexed citations

Benabdallah, Basma, Joël Rousseau, Pierre Chapdelaine, et al.. (2013). Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Molecular Therapy — Nucleic Acids. 2. e68–e68. 16 indexed citations

Tremblay, Jacques P., et al.. (2012). Transcription Activator-Like Effector Proteins Induce the Expression of the Frataxin Gene. Human Gene Therapy. 23(8). 883–890. 30 indexed citations

10.

Palmieri, Beniamino, Jacques P. Tremblay, & Daniele Lodi. (2010). Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy. Pediatric Transplantation. 14(7). 813–819. 41 indexed citations

11.

Camirand, Geoffrey, Joël Rousseau, Nicolas Caron, et al.. (2008). Central Tolerance to Myogenic Cell Transplants Does Not Include Muscle Neoantigens. Transplantation. 85(12). 1791–1801. 9 indexed citations

12.

Péault, Bruno, Michael A. Rudnicki, Yvan Torrente, et al.. (2007). Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy. Molecular Therapy. 15(5). 867–877. 423 indexed citations

13.

Camirand, Geoffrey, et al.. (2004). Novel Duchenne Muscular Dystrophy Treatment Through Myoblast Transplantation Tolerance with Anti-CD45RB, Anti-CD154 and Mixed Chimerism. American Journal of Transplantation. 4(8). 1255–1265. 22 indexed citations

14.

Fahime, Elmostafa El, Manaf Bouchentouf, Basma Benabdallah, et al.. (2003). Tubulyzine^®, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochemistry and Cell Biology. 81(2). 81–90. 20 indexed citations

15.

Skuk, Daniel, Denis Furling, Jean‐Pierre Bouchard, et al.. (1999). Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy. Journal of Neuropathology & Experimental Neurology. 58(9). 921–931. 20 indexed citations

16.

Hallauer, Patricia L., et al.. (1998). Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast. Muscle & Nerve. 21(3). 291–297. 2 indexed citations

17.

Kinoshita, Ikuo, Jean‐Thomas Vilquin, B. Guérette, et al.. (1994). Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle & Nerve. 17(12). 1407–1415. 154 indexed citations

18.

Sansone, Valerio, G Rotondo, Giovanni Bottiroli, Jacques P. Tremblay, & G. Meola. (1993). Cytoplasmic restoration and persistence of glucose-6-phosphate dehydrogenase activity in stable hybrid myotubes.. PubMed. 37(3). 241–8. 1 indexed citations

19.

Fortier, Louis‐Philippe, et al.. (1991). A monoclonal antibody to conotoxin reveals the distribution of a subset of calcium channels in the rat cerebellar cortex. Molecular Brain Research. 9(3). 209–215. 12 indexed citations

20.

Hamet, Pavel, et al.. (1990). Genetic hypertension is characterized by the abnormal expression of a gene localized in major histocompatibility complex HSP70.. PubMed. 22(6). 2566–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact